Everolimus Eluting Coronary Stent System
- UID
- MFG/MD/2018/000028_c87d460d00d3564b32bb8aea8cee3662_d77c83a89b1600be60f67df56247142d
- Device class
- Class D
- Brand name
- First Brand
- License holder
- Meril Life Sciences Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- For Cylindrical Models: It is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo & in-stent restenotic lesions (First Brand) in native coronary arteries with a reference vessel diameter of 2.00 mm to 4.50 mm in patients eligible for Percutaneous Transluminal Coronary Angioplasty (First Brand) and Stenting procedures. For Taper Model: It is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo & in-stent restenotic lesions (First Brand) in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.50 mm in patients eligible for Percutaneous Transluminal Coronary Angioplasty (First Brand) and Stenting procedures
Everolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000028_c87d460d00d3564b32bb8aea8cee3662_d77c83a89b1600be60f67df56247142d. This device is marketed under the brand name First Brand. The license holder is Meril Life Sciences Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.